B. Lacour, A. Guyot-goubin, S. Guissou, S. Bellec, E. Désandes et al., Incidence of childhood cancer in France: National Children Cancer Registries, 2000???2004, European Journal of Cancer Prevention, vol.19, issue.3, pp.173-81, 2000.
DOI : 10.1097/CEJ.0b013e32833876c0

E. Desandes, C. Berger, I. Tron, F. Demeocq, S. Bellec et al., Childhood cancer survival in France, 1990???1999, European Journal of Cancer, vol.44, issue.2, pp.205-220, 1990.
DOI : 10.1016/j.ejca.2007.11.016

URL : https://hal.archives-ouvertes.fr/inserm-00250348

M. Geenen, M. Cardous-ubbink, L. Kremer, C. Van-den-bos, H. Van-der-pal et al., Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer, JAMA, vol.297, issue.24, pp.2705-2720, 2007.
DOI : 10.1001/jama.297.24.2705

Y. Pointreau, S. Kreps, and C. Hennequin, Side effects evaluation of ionizing radiation]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5246, 2010.

M. Metzger, Current Therapy for Wilms' Tumor. The Oncologist, Nov, vol.110, issue.10, pp.815-841, 2005.

B. Broecker, NON???WILMS' RENAL TUMORS IN CHILDREN, Urologic Clinics of North America, vol.27, issue.3, 2000.
DOI : 10.1016/S0094-0143(05)70094-X

A. Ludin and R. Macklis, RADIOTHERAPY FOR PEDIATRIC GENITOURINARY TUMORS, Urologic Clinics of North America, vol.27, issue.3, pp.553-62, 2000.
DOI : 10.1016/S0094-0143(05)70102-6

N. Breslow, A. Olshan, J. Beckwith, and D. Green, Epidemiology of Wilms tumor, Medical and Pediatric Oncology, vol.13, issue.3, pp.172-81, 1993.
DOI : 10.1002/mpo.2950210305

N. Breslow and J. Beckwith, Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study, J Natl Cancer Inst, vol.68, issue.3, pp.429-465, 1982.

D. Green, D. Fernbach, P. Norkool, G. Kollia, D. Angio et al., The treatment of Wilms' tumor patients with pulmonary metastases detected only with computed tomography: a report from the National Wilms' Tumor Study., Journal of Clinical Oncology, vol.9, issue.10, pp.1776-81, 1991.
DOI : 10.1200/JCO.1991.9.10.1776

S. Dumoucel, M. Gauthier-villars, D. Stoppa-lyonnet, P. Parisot, H. Brisse et al., Malformations, genetic abnormalities, and Wilms tumor. Pediatr Blood Cancer, pp.140-144, 2014.

R. Scott, C. Stiller, L. Walker, and N. Rahman, Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour, Journal of Medical Genetics, vol.43, issue.9, pp.705-720, 2006.
DOI : 10.1136/jmg.2006.041723

A. Ng, A. Griffiths, T. Cole, V. Davison, M. Griffiths et al., Congenital abnormalities and clinical features associated with Wilms??? tumour: A comprehensive study from a centre serving a large population, European Journal of Cancer, vol.43, issue.9, 1990.
DOI : 10.1016/j.ejca.2007.03.020

E. Rose, T. Glaser, C. Jones, C. Smith, W. Lewis et al., Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene, Cell, vol.60, issue.3, pp.495-508, 1990.
DOI : 10.1016/0092-8674(90)90600-J

B. Royer-pokora, M. Beier, M. Henzler, R. Alam, V. Schumacher et al., Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development, Am J Med Genet A, vol.127, issue.3, pp.249-57, 2004.

R. Miller, J. Fraumeni, . Jr, and M. Manning, Association of Wilms's Tumor with Aniridia, Hemihypertrophy and Other Congenital Malformations, New England Journal of Medicine, vol.270, issue.18, pp.922-929, 1964.
DOI : 10.1056/NEJM196404302701802

V. Riccardi, E. Sujansky, A. Smith, and U. Francke, Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion, Pediatrics, 1978.

A. Eddy and S. Mauer, Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): Frequency in end-stage renal failure, The Journal of Pediatrics, vol.106, issue.4, pp.584-591, 1985.
DOI : 10.1016/S0022-3476(85)80076-7

A. Drash, F. Sherman, W. Hartmann, and R. Blizzard, A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease, The Journal of Pediatrics, vol.76, issue.4, pp.585-93, 1970.
DOI : 10.1016/S0022-3476(70)80409-7

R. Mueller, The Denys-Drash syndrome., Journal of Medical Genetics, vol.31, issue.6, pp.471-478, 1994.
DOI : 10.1136/jmg.31.6.471

N. Hastie, Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome???proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development, Human Molecular Genetics, vol.1, issue.5, pp.293-298, 1992.
DOI : 10.1093/hmg/1.5.293

R. Mueller, The Denys-Drash syndrome., Journal of Medical Genetics, vol.31, issue.6, pp.471-478, 1994.
DOI : 10.1136/jmg.31.6.471

J. Pelletier, W. Bruening, C. Kashtan, S. Mauer, J. Manivel et al., Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome, Cell, vol.67, issue.2, pp.437-484, 1991.
DOI : 10.1016/0092-8674(91)90194-4

S. Barbaux, P. Niaudet, M. Gubler, J. Grünfeld, F. Jaubert et al., Donor splice-site mutations in WT1 are responsible for Frasier syndrome, Nature Genetics, vol.11, issue.4, 1997.
DOI : 10.1038/ng1297-467

F. Poulat, D. Morin, A. König, P. Brun, J. Giltay et al., Distinct molecular origins for Denys-Drash and Frasier syndromes, Human Genetics, vol.91, issue.3, pp.285-291, 1993.
DOI : 10.1007/BF00218274

S. Little, S. Hanks, L. King-underwood, C. Jones, E. Rapley et al., Mutations in Nonsyndromic Wilms' Tumor Patients: A UK Children???s Cancer Study Group Study, Journal of Clinical Oncology, vol.22, issue.20, pp.4140-4146, 2004.
DOI : 10.1200/JCO.2004.02.136

M. Elliott, R. Bayly, T. Cole, I. Temple, and E. Maher, Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases, Clinical Genetics, vol.1, issue.2, 1994.
DOI : 10.1111/j.1399-0004.1994.tb04219.x

P. Choyke, M. Siegel, O. Oz, C. Sotelo-avila, and M. Debaun, Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome, AJR Am J Roentgenol, 1998.

M. Debaun and M. Tucker, Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry, The Journal of Pediatrics, vol.132, issue.3, pp.398-400, 1998.
DOI : 10.1016/S0022-3476(98)70008-3

H. Wiedemann, Frequency of Wiedemann-Beckwith syndrome in Germany; rate of hemihyperplasia and of tumours in affected children, Eur J Pediatr, 1997.

M. Porteus, P. Narkool, D. Neuberg, K. Guthrie, N. Breslow et al., Characteristics and Outcome of Children With Beckwith-Wiedemann Syndrome and Wilms??? Tumor: A Report From the National Wilms Tumor Study Group, Journal of Clinical Oncology, vol.18, issue.10, pp.2026-2057, 2000.
DOI : 10.1200/JCO.2000.18.10.2026

R. Weksberg, A. Smith, J. Squire, and P. Sadowski, Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development, Human Molecular Genetics, vol.12, issue.90001, pp.61-68, 2003.
DOI : 10.1093/hmg/ddg067

N. Rahman, Mechanisms predisposing to childhood overgrowth and cancer, Current Opinion in Genetics & Development, vol.15, issue.3, pp.227-260, 2005.
DOI : 10.1016/j.gde.2005.04.007

J. Bliek, C. Gicquel, S. Maas, V. Gaston, L. Bouc et al., Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS), The Journal of Pediatrics, vol.145, issue.6, pp.796-805, 2004.
DOI : 10.1016/j.jpeds.2004.08.007

M. Debaun, E. Niemitz, D. Mcneil, S. Brandenburg, M. Lee et al., Epigenetic Alterations of H19 and LIT1 Distinguish Patients with Beckwith-Wiedemann Syndrome with Cancer and Birth Defects, The American Journal of Human Genetics, vol.70, issue.3, pp.604-615, 2002.
DOI : 10.1086/338934

G. Pilia, R. Hughes-benzie, A. Mackenzie, P. Baybayan, E. Chen et al., Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome, Nature Genetics, vol.227, issue.3, pp.241-248, 1996.
DOI : 10.1038/372464a0

R. Hughes-benzie, G. Pilia, J. Xuan, A. Hunter, E. Chen et al., Simpson-Golabi-Behmel syndrome: Genotype/phenotype analysis of 18 affected males from 7 unrelated families, American Journal of Medical Genetics, vol.3, issue.2, pp.227-261, 1996.
DOI : 10.1002/(SICI)1096-8628(19961211)66:2<227::AID-AJMG20>3.0.CO;2-U

H. Henneveld, R. Van-lingen, B. Hamel, I. Stolte-dijkstra, and A. Van-essen, Perlman syndrome: Four additional cases and review, American Journal of Medical Genetics, vol.35, issue.5, pp.439-485, 1999.
DOI : 10.1002/(SICI)1096-8628(19991029)86:5<439::AID-AJMG9>3.0.CO;2-4

G. Neri, M. Martini-neri, B. Katz, and J. Opitz, The Perlman syndrome: Familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies, American Journal of Medical Genetics, vol.61, issue.1, pp.195-207, 1984.
DOI : 10.1002/ajmg.1320190120

M. Morris, D. Astuti, and E. Maher, Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2, Am J Med Genet C Semin Med Genet, 2013.

G. Baujat, M. Rio, S. Rossignol, D. Sanlaville, S. Lyonnet et al., Paradoxical NSD1 Mutations in Beckwith-Wiedemann Syndrome and 11p15 Anomalies in Sotos Syndrome, The American Journal of Human Genetics, vol.74, issue.4, pp.715-735, 2004.
DOI : 10.1086/383093

H. Hoyme, L. Seaver, K. Jones, F. Procopio, W. Crooks et al., Isolated hemihyperplasia (hemihypertrophy): Report of a prospective multicenter study of the incidence of neoplasia and review, American Journal of Medical Genetics, vol.141, issue.4, pp.274-282, 1998.
DOI : 10.1002/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.0.CO;2-M

L. Thompson, Unraveling the Fanconi anemia???DNA repair connection, Nature Genetics, vol.37, issue.9, pp.921-923, 2005.
DOI : 10.1074/jbc.C000337200

S. Reid, A. Renwick, S. Seal, L. Baskcomb, R. Barfoot et al., Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour, Journal of Medical Genetics, vol.42, issue.2, pp.147-51, 2005.
DOI : 10.1136/jmg.2004.022673

B. Hirsch, A. Shimamura, L. Moreau, S. Baldinger, M. Hag-alshiekh et al., Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood, Blood, vol.103, issue.7, pp.2554-2563, 2004.
DOI : 10.1182/blood-2003-06-1970

S. Hanks, K. Coleman, S. Reid, A. Plaja, H. Firth et al., Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B, Nature Genetics, vol.62, issue.11, pp.1159-61, 2004.
DOI : 10.1038/32688

H. Kawame, Y. Sugio, Y. Fuyama, Y. Hayashi, H. Suzuki et al., Syndrome of microcephaly, Dandy-Walker malformation, and Wilms tumor caused by mosaic variegated aneuploidy with premature centromere division (PCD): report of a new case and review of the literature, Journal of Human Genetics, vol.44, issue.4, pp.219-243, 1999.
DOI : 10.1007/s100380050147

N. Breslow, J. Olson, J. Moksness, J. Beckwith, and P. Grundy, Familial Wilms' tumor: A descriptive study, Medical and Pediatric Oncology, vol.20, issue.5, pp.398-403, 1996.
DOI : 10.1002/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H

C. Kaplinsky, M. Ghahremani, Y. Frishberg, G. Rechavi, and J. Pelletier, Familial Wilms??? Tumor Associated with a WT1 Zinc Finger Mutation, Genomics, vol.38, issue.3, pp.451-454, 1996.
DOI : 10.1006/geno.1996.0655

S. Reid, A. Renwick, S. Seal, L. Baskcomb, R. Barfoot et al., Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour, Journal of Medical Genetics, vol.42, issue.2, pp.147-51, 2005.
DOI : 10.1136/jmg.2004.022673

N. Rahman, L. Arbour, P. Tonin, J. Renshaw, J. Pelletier et al., Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12???q21, Nature Genetics, vol.86, issue.4, 1996.
DOI : 10.1038/362749a0

N. Rahman, F. Abidi, D. Ford, L. Arbour, E. Rapley et al., Confirmation of FWT1 as a Wilms??? tumour susceptibility gene and phenotypic characteristics of Wilms??? tumour attributable to FWT1, Human Genetics, vol.103, issue.5, pp.547-56, 1998.
DOI : 10.1007/PL00008708

E. Rapley, R. Barfoot, C. Bonaïti-pellié, A. Chompret, W. Foulkes et al., Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2, Br J Cancer, vol.83, issue.2, pp.177-83, 2000.

J. Beckwith, Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations, American Journal of Medical Genetics, vol.8, issue.4, pp.268-73, 1998.
DOI : 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I

J. Beckwith, N. Kiviat, and J. Bonadio, Nephrogenic Rests, Nephroblastomatosis, and the Pathogenesis of Wilms' Tumor, Pediatric Pathology, vol.55, issue.1-2, pp.1-36, 1990.
DOI : 10.1038/336374a0

R. Fukuzawa, M. Anaka, R. Heathcott, L. Mcnoe, I. Morison et al., Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes, The Journal of Pathology, vol.45, issue.4, pp.377-87, 2008.
DOI : 10.1002/path.2366

C. Bergeron and S. Protocole, Nephroblastoma Clinical trial & Study, 2001.

R. Bolande, A. Brough, and R. Izant, Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics, 1967.

Z. Wang, K. Li, K. Dong, X. Xiao, and S. Zheng, Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature, Oncology Letters, 2014.
DOI : 10.3892/ol.2014.2489

M. Bisceglia, I. Carosi, M. Vairo, L. Zaffarano, M. Bisceglia et al., Congenital Mesoblastic Nephroma: Report of a Case with Review of the Most Significant Literature, Pathology - Research and Practice, vol.196, issue.3, pp.199-204, 2000.
DOI : 10.1016/S0344-0338(00)80101-6

M. Van-den-heuvel-eibrink, P. Grundy, N. Graf, K. Pritchard-jones, C. Bergeron et al., Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups, Pediatric Blood & Cancer, vol.20, issue.6, pp.1130-1134, 2008.
DOI : 10.1002/pbc.21389

N. Lal and A. Singhai, Clear cell sarcoma of kidney: A rare entity, Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol, vol.32, issue.3, pp.157-166, 2011.

A. Sukdevjadhav, S. Jain, N. Tuteja, and L. Agrawal, Clear Cell Sarcoma of Kidney in a Neonate Available from, J Neonatal Surg, vol.3, issue.3, 2014.

P. Argani, E. Perlman, N. Breslow, N. Browning, D. Green et al., Clear Cell Sarcoma of the Kidney, The American Journal of Surgical Pathology, vol.24, issue.1, pp.4-18, 2000.
DOI : 10.1097/00000478-200001000-00002

D. Green, N. Breslow, J. Beckwith, J. Finklestein, P. Grundy et al., Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group., Journal of Clinical Oncology, vol.16, issue.1, pp.237-282, 1998.
DOI : 10.1200/JCO.1998.16.1.237

N. Seibel, S. Li, N. Breslow, J. Beckwith, D. Green et al., Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms' Tumor Study Group, Journal of Clinical Oncology, vol.22, issue.3, pp.468-73, 2004.
DOI : 10.1200/JCO.2004.06.058

R. Furtwängler, S. Gooskens, H. Van-tinteren, J. De-kraker, G. Schleiermacher et al., Clear Cell Sarcomas of the Kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: A report of the SIOP Renal Tumour Study Group, European Journal of Cancer, vol.49, issue.16, pp.3497-506, 1990.
DOI : 10.1016/j.ejca.2013.06.036

B. Brennan, C. Stiller, and F. Bourdeaut, Extracranial rhabdoid tumours: what we have learned so far and future directions, The Lancet Oncology, vol.14, issue.8, pp.329-336, 2013.
DOI : 10.1016/S1470-2045(13)70088-3

G. Toth, C. Zraly, T. Thomson, C. Jones, S. Lapetino et al., Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor, Genes, Chromosomes and Cancer, vol.294, issue.6, 2011.
DOI : 10.1002/gcc.20862

C. Roberts and J. Biegel, The role of SMARCB1/INI1 in the development of rhabdoid tumors, Cancer Biology & Therapy, vol.8, issue.5, pp.412-418, 2009.
DOI : 10.4161/cbt.8.5.8019

G. Tomlinson, N. Breslow, J. Dome, K. Guthrie, P. Norkool et al., Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic Factor, Journal of Clinical Oncology, vol.23, issue.30, pp.7641-7646, 2005.
DOI : 10.1200/JCO.2004.00.8110

. Age, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer, pp.35-40, 2010.

G. Cecchetto, E. Carretto, G. Bisogno, P. Dall-'igna, A. Ferrari et al., Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee, Pediatric Blood & Cancer, vol.17, issue.5, pp.593-600, 2008.
DOI : 10.1002/pbc.21702

S. Terezakis and M. Wharam, Radiotherapy for Rhabdomyosarcoma: Indications and Outcome, Clinical Oncology, vol.25, issue.1, pp.27-35
DOI : 10.1016/j.clon.2012.07.009

S. Wolden, J. Anderson, W. Crist, J. Breneman, M. Wharam et al., Indications for Radiotherapy and Chemotherapy After Complete Resection in Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Studies I to III, Journal of Clinical Oncology, vol.17, issue.11, pp.3468-75, 1999.
DOI : 10.1200/JCO.1999.17.11.3468

S. Donaldson, J. Meza, J. Breneman, W. Crist, F. Laurie et al., Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma???a report from the IRSG, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.3, pp.718-746, 2001.
DOI : 10.1016/S0360-3016(01)01709-6

G. Ferron and J. Gilly, Tumeurs desmoplastiques à petites cellules

F. Arnaldez and D. Loeb, Tumeurs desmoplastiques à petites cellules rondes. Sarcomahelp

M. Lae, P. Roche, J. L. Lloyd, R. Nascimento, and A. , Desmoplastic Small Round Cell Tumor, The American Journal of Surgical Pathology, vol.26, issue.7
DOI : 10.1097/00000478-200207000-00001

R. Saab, J. Khoury, M. Krasin, A. Davidoff, and F. Navid, Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer, pp.274-283, 2007.

K. Mahadik and K. Ghorpade, Childhood Ovarian Malignancy, The Journal of Obstetrics and Gynecology of India, vol.76, issue.2, pp.91-95
DOI : 10.1007/s13224-014-0533-4

S. Tangjitgamol, J. Hanprasertpong, S. Manusirivithaya, V. Wootipoom, T. Thavaramara et al., Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes, Acta Obstetricia et Gynecologica Scandinavica, vol.89, issue.2, pp.182-191, 2010.
DOI : 10.3109/00016340903443684

I. Ray-coquard and E. Pujade-lauraine, Les tumeurs rares de l'ovaire

L. Cheng, L. Roth, S. Zhang, M. Wang, M. Morton et al., KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer, pp.2096-103, 2011.

O. Solheim, D. Gershenson, C. Tropé, E. Rokkones, C. Sun et al., Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978???2010), European Journal of Cancer, vol.50, issue.11, pp.1942-50, 1990.
DOI : 10.1016/j.ejca.2014.03.288

M. Andrés, E. Costa, A. Cañete, L. Moreno, and V. Castel, Solid ovarian tumours in childhood: a 35-year review in a single institution Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex, pp.287-91, 2010.

X. Sun, Q. Yang, Z. Zhen, Y. Xia, Z. Huang et al., Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases], Ai Zheng Aizheng Chin J Cancer, vol.25, issue.12, pp.1529-1561, 2006.

J. Cosset, Side effects of ionizing radiation on healthy tissues and organs at risk]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5228, 2010.

S. Bentzen, Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology, Nature Reviews Cancer, vol.46, issue.659, pp.702-715, 2006.
DOI : 10.1038/nrc1950

J. Tomasek, G. Gabbiani, B. Hinz, C. Chaponnier, and R. Brown, Myofibroblasts and mechano-regulation of connective tissue remodelling, Nature Reviews Molecular Cell Biology, vol.3, issue.5, pp.349-63, 2002.
DOI : 10.1038/nrm809

R. Elston and G. Inman, Crosstalk between p53 and TGF-? Signalling, J Signal Transduct, vol.2012, p.294097, 2012.

F. Milliat, J. Sabourin, G. Tarlet, V. Holler, E. Deutsch et al., Essential Role of Plasminogen Activator Inhibitor Type-1 in Radiation Enteropathy, The American Journal of Pathology, vol.172, issue.3, 2008.
DOI : 10.2353/ajpath.2008.070930

D. Brenner, R. Doll, D. Goodhead, E. Hall, C. Land et al., Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.13761-13767, 2003.
DOI : 10.1073/pnas.2235592100

D. Brenner and R. Sachs, Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach, Radiation and Environmental Biophysics, vol.164, issue.4, pp.253-259, 2006.
DOI : 10.1007/s00411-006-0029-4

J. Doyen, A. Courdi, and J. Gérard, Second primitive malignant neoplasm after radiotherapy]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5255, 2010.

I. Diallo, N. Haddy, E. Adjadj, A. Samand, E. Quiniou et al., Frequency Distribution of Second Solid Cancer Locations in Relation to the Irradiated Volume Among 115 Patients Treated for Childhood Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.3, pp.876-83, 2009.
DOI : 10.1016/j.ijrobp.2009.01.040

K. Rothkamm and M. Löbrich, Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses, Proceedings of the National Academy of Sciences, vol.100, issue.9, pp.5057-62, 2003.
DOI : 10.1073/pnas.0830918100

T. Henderson, P. Rajaraman, M. Stovall, L. Constine, A. Olive et al., Risk Factors Associated With Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.1, pp.224-254, 2012.
DOI : 10.1016/j.ijrobp.2011.11.022

D. Friedman, J. Whitton, W. Leisenring, A. Mertens, S. Hammond et al., Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study, JNCI Journal of the National Cancer Institute, vol.102, issue.14, pp.1083-95, 2010.
DOI : 10.1093/jnci/djq238

I. Van-dijk, F. Oldenburger, M. Cardous-ubbink, M. Geenen, R. Heinen et al., Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.2, pp.370-378, 2010.
DOI : 10.1016/j.ijrobp.2009.08.016

A. Paulino, B. Wen, C. Brown, R. Tannous, N. Mayr et al., Late effects in children treated with radiation therapy for Wilms??? tumor, International Journal of Radiation Oncology*Biology*Physics, vol.46, issue.5, pp.1239-1285, 2000.
DOI : 10.1016/S0360-3016(99)00534-9

K. Wright, D. Green, and N. Daw, LATE EFFECTS OF TREATMENT FOR WILMS TUMOR, Pediatric Hematology and Oncology, vol.56, issue.6, pp.407-420, 2009.
DOI : 10.1056/NEJM198709033171002

E. Martin, Y. Pointreau, S. Roche-forestier, and I. Barillot, Normal tissue tolerance to external beam radiation therapy: small bowel]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5350, 2010.

L. Coia, R. Myerson, and J. Tepper, Late effects of radiation therapy on the gastrointestinal tract, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1213-1249, 1995.
DOI : 10.1016/0360-3016(94)00419-L

O. Hatoum, D. Binion, S. Phillips, O. Loughlin, C. Komorowski et al., Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction, Gut, vol.54, issue.12, pp.1797-800, 2005.
DOI : 10.1136/gut.2005.073734

J. Andreyev, Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients, The Lancet Oncology, vol.8, issue.11, pp.1007-1024, 2007.
DOI : 10.1016/S1470-2045(07)70341-8

R. Taylor, Morbidity from abdominal radiotherapy in the first United Kingdom Children's Cancer Study Group Wilms' Tumour Study, Clinical Oncology, vol.9, issue.6, pp.381-385, 1997.
DOI : 10.1016/S0936-6555(97)80131-8

T. Bölling, U. Dirksen, A. Ranft, I. Ernst, H. Jürgens et al., Radiation Toxicity Following Busulfan/Melphalan High-dose Chemotherapy in the EURO-EWING-99-trial: Review of GPOH Data, Strahlentherapie und Onkologie, vol.184, issue.Sondernr.2, pp.21-23, 2009.
DOI : 10.1007/s00066-009-1009-9

J. Robertson, D. Lockman, D. Yan, and M. Wallace, The Dose???Volume Relationship of Small Bowel Irradiation and Acute Grade 3 Diarrhea During Chemoradiotherapy for Rectal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.2, pp.413-421, 2008.
DOI : 10.1016/j.ijrobp.2007.06.066

B. Minsky, J. Conti, Y. Huang, and K. Knopf, Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer., Journal of Clinical Oncology, vol.13, issue.6, pp.1409-1425, 1995.
DOI : 10.1200/JCO.1995.13.6.1409

M. Ritchey, P. Kelalis, R. Etzioni, N. Breslow, S. Shochat et al., Small Bowel Obstruction After Nephrectomy for Wilms?? Tumor, Annals of Surgery, vol.218, issue.5, pp.654-663, 1993.
DOI : 10.1097/00000658-199321850-00011

M. Van-waas, S. Neggers, H. Raat, C. Van-rij, R. Pieters et al., Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors, PLoS ONE, vol.121, issue.12, p.52237, 2012.
DOI : 10.1371/journal.pone.0052237.t003

D. Vathaire, F. El-fayech, C. , B. Ayed, F. Haddy et al., Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study, The Lancet Oncology, vol.13, issue.10, pp.1002-1012, 2012.
DOI : 10.1016/S1470-2045(12)70323-6

M. Geenen, P. Bakker, L. Kremer, J. Kastelein, and F. Van-leeuwen, Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer, pp.690-697, 2010.

E. Gillette, P. Mahler, B. Powers, S. Gillette, and Z. Vujaskovic, Late radiation injury to muscle and peripheral nerves, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1309-1327, 1995.
DOI : 10.1016/0360-3016(94)00422-H

W. Wallace, S. Shalet, M. , P. Swindell, R. Gattamaneni et al., Effect of abdominal irradiation on growth in boys treated for a wilms??? tumor, Medical and Pediatric Oncology, vol.147, issue.6, pp.441-447, 1990.
DOI : 10.1002/mpo.2950180602

S. Shalet, B. Gibson, R. Swindell, and D. Pearson, Effect of spinal irradiation on growth., Archives of Disease in Childhood, vol.62, issue.5, pp.461-465, 1987.
DOI : 10.1136/adc.62.5.461

K. Willman, R. Cox, and S. Donaldson, Radiation induced height impairment in pediatric Hodgkin's disease, International Journal of Radiation Oncology*Biology*Physics, vol.28, issue.1, pp.85-92, 1994.
DOI : 10.1016/0360-3016(94)90144-9

P. Eifel, S. Donaldson, and P. Thomas, Response of growing bone to irradiation: A proposed late effects scoring system, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1301-1308, 1995.
DOI : 10.1016/0360-3016(94)00420-P

J. Oliver, G. Gluck, R. Gledhill, and C. L. , Musculoskeletal deformities following treatment of Wilms' tumour, Can Med Assoc J, vol.119, issue.5, pp.459-64, 1978.

A. Mäkipernaa, J. Heikkilä, J. Merikanto, E. Marttinen, and M. Siimes, Spinal deformity induced by radiotherapy for solid tumours in childhood: A long-term follow up study, European Journal of Pediatrics, vol.18, issue.3
DOI : 10.1007/BF01956143

E. Willich, H. Kuttig, G. Pfeil, and P. Scheibel, Vertebral changes after irradiation for Wilms' tumor in early childhood. A retrospective interdisciplinary long-term study of 82 children]. Strahlenther Onkol Organ Dtsch Röntgenges Al, pp.815-836, 1990.

W. Dörr, S. Kallfels, and T. Herrmann, Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated between, Strahlenther Onkol Organ Dtsch Röntgenges Al, 1970.

S. Castellino, A. Muir, A. Shah, S. Shope, K. Mcmullen et al., Hepato-Biliary Late Effects in Survivors of Childhood and Adolescent Cancer: A Report from the Children's Oncology Group. Pediatr Blood Cancer, pp.663-672, 2010.

C. Bouyn, J. Leclere, G. Raimondo, H. Le-pointe, D. Couanet et al., Hepatic focal nodular hyperplasia in children previously treated for a solid tumor, Cancer, vol.61, issue.12, pp.3107-3120, 2003.
DOI : 10.1002/cncr.11452

E. Citak, C. Karadeniz, A. Oguz, O. Boyunaga, O. Ekinci et al., NODULAR REGENERATIVE HYPERPLASIA AND FOCAL NODULAR HYPERPLASIA OF THE LIVER MIMICKING HEPATIC METASTASIS IN CHILDREN WITH SOLID TUMORS AND A REVIEW OF LITERATURE, Pediatric Hematology and Oncology, vol.24, issue.4, 2007.
DOI : 10.1002/hep.1840040121

L. Anderson, D. Gregg, D. Margolis, J. Casper, and J. Talano, Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series, Bone Marrow Transplantation, vol.85, issue.8, pp.1357-1366, 2010.
DOI : 10.1007/s00261-001-0140-6

N. Breslow, A. Collins, M. Ritchey, Y. Grigoriev, S. Peterson et al., END STAGE RENAL DISEASE IN PATIENTS WITH WILMS TUMOR: RESULTS FROM THE NATIONAL WILMS TUMOR STUDY GROUP AND THE UNITED STATES RENAL DATA SYSTEM, The Journal of Urology, vol.174, issue.5, pp.1972-1977, 2005.
DOI : 10.1097/01.ju.0000176800.00994.3a

E. Bárdi, A. Oláh, K. Bartyik, E. Endreffy, C. Jenei et al., Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer, pp.668-73, 2004.

N. Daw, D. Gregornik, J. Rodman, N. Marina, J. Wu et al., Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour, European Journal of Cancer, vol.45, issue.1, pp.99-106, 2009.
DOI : 10.1016/j.ejca.2008.09.017

S. Wong-hee-kam and F. Huguet, Normal tissue tolerance to external beam radiation therapy: kidney]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5340, 2010.

R. Anderson, R. Mitchell, T. Kelsey, N. Spears, E. Telfer et al., Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults, The Lancet Diabetes & Endocrinology, vol.3, issue.7, 2015.
DOI : 10.1016/S2213-8587(15)00039-X

W. Wallace, S. Shalet, E. Crowne, M. , P. Gattamaneni et al., Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis, Clinical Oncology, vol.1, issue.2, pp.75-84, 1989.
DOI : 10.1016/S0936-6555(89)80039-1

A. Schuck, V. Hamelmann, J. Brämswig, S. Könemann, C. Rübe et al., Ovarialfunktion nach Beckenbestrahlung bei M??dchen und jungen Frauen, Strahlentherapie und Onkologie, vol.181, issue.8, pp.534-543, 2005.
DOI : 10.1007/s00066-005-9500-4

E. Gross, C. Champetier, Y. Pointreau, A. Zaccariotto, T. Dubergé et al., Normal tissue tolerance to external beam radiation therapy: ovaries]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5373, 2010.

E. Thibaud, M. Ramirez, R. Brauner, F. Flamant, J. Zucker et al., Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood, The Journal of Pediatrics, vol.121, issue.6, pp.880-884, 1992.
DOI : 10.1016/S0022-3476(05)80332-4

E. Stöckle, G. Verdier, L. Thomas, E. Bussières, A. Avril et al., Functional outcome of laparoscopically transposed ovaries in the multidisciplinary treatment of cervical cancers. Analysis of risk factors], J Gynécologie Obstétrique Biol Reprod, vol.25, issue.3, pp.244-52, 1996.

M. Dolmans, S. Hollanders-de-ouderaen, D. Demylle, and C. Pirard, Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment, Journal of Assisted Reproduction and Genetics, vol.9, issue.12, 2015.
DOI : 10.1007/s10815-015-0533-z

I. Demeestere, P. Simon, L. Dedeken, F. Moffa, S. Tsépélidis et al., Live birth after autograft of ovarian tissue cryopreserved during childhood: Figure 1, Human Reproduction, vol.30, issue.9, 2009.
DOI : 10.1093/humrep/dev128

G. Fasano, F. Moffa, J. Dechène, Y. Englert, and I. Demeestere, Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation, Reproductive Biology and Endocrinology, vol.9, issue.1, p.150, 2011.
DOI : 10.1016/j.fertnstert.2008.04.014

A. Revel, S. Vilk, E. Aizenman, A. Porat-katz, A. Safran et al., At what age can human oocytes be obtained? Fertil Steril, pp.458-63, 2009.

E. Ernst, M. Kjaersgaard, N. Birkebaek, N. Clausen, and C. Andersen, Case report: Stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue, European Journal of Cancer, vol.49, issue.4, pp.911-915, 1990.
DOI : 10.1016/j.ejca.2012.09.028

C. Poirot, F. Abirached, M. Prades, C. Coussieu, F. Bernaudin et al., Induction of puberty by autograft of cryopreserved ovarian tissue, The Lancet, vol.379, issue.9815, p.588, 2012.
DOI : 10.1016/S0140-6736(11)61781-9

A. Azarbaijani, B. Sheikhi, M. Oskam, I. Nurmio, M. Laine et al., Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro, PLOS ONE, vol.11, issue.7, p.133985, 2015.
DOI : 10.1371/journal.pone.0133985.t004

D. Edgar and D. Gook, A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update, pp.536-54, 2012.

D. Green, E. Peabody, N. B. Peterson, S. Kalapurakal, J. Breslow et al., Pregnancy Outcome After Treatment for Wilms Tumor: A Report From the National Wilms Tumor Study Group, Journal of Clinical Oncology, vol.20, issue.10, pp.2506-2519, 2002.
DOI : 10.1200/JCO.2002.07.159

J. Kalapurakal, S. Peterson, E. Peabody, P. Thomas, D. Green et al., Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.5, pp.1364-1372, 2004.
DOI : 10.1016/j.ijrobp.2003.08.031

M. Laufer, J. Upton, S. Schuster, H. Grier, S. Emans et al., Ovarian Tissue Autologous Transplantation to the Upper Extremity for Girls Receiving Abdominal/Pelvic Radiation: 20-year Follow-up of Reproductive Endocrine Function, Journal of Pediatric and Adolescent Gynecology, vol.23, issue.2, pp.107-117, 2010.
DOI : 10.1016/j.jpag.2009.09.005

N. Breslow, J. Takashima, J. Whitton, J. Moksness, D. Angio et al., Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group., Journal of Clinical Oncology, vol.13, issue.8, 1995.
DOI : 10.1200/JCO.1995.13.8.1851

M. Carli, L. Simonato, E. Frascella, M. Tournade, J. De-kraker et al., Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6, Medical and Pediatric Oncology, vol.59, issue.4, pp.239-283, 1997.
DOI : 10.1002/(SICI)1096-911X(199710)29:4<239::AID-MPO1>3.0.CO;2-N

D. Vathaire, F. Hawkins, M. Campbell, S. Oberlin, O. Raquin et al., Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment, British Journal of Cancer, vol.51, issue.11-12, pp.11-121884, 1999.
DOI : 10.1038/sj.bjc.6690300

H. Jenkinson, M. Hawkins, C. Stiller, D. Winter, H. Marsden et al., Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain, British Journal of Cancer, vol.16, issue.11, pp.1905-1915, 2004.
DOI : 10.1093/jnci/93.8.618

A. Meadows, D. Friedman, J. Neglia, A. Mertens, S. Donaldson et al., Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort, Journal of Clinical Oncology, vol.27, issue.14, pp.2356-62, 2009.
DOI : 10.1200/JCO.2008.21.1920

C. Chargari and J. Cosset, The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies], Bull Cancer

J. Neglia, D. Friedman, Y. Yasui, A. Mertens, S. Hammond et al., Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study, JNCI Journal of the National Cancer Institute, vol.93, issue.8, pp.618-647, 2001.
DOI : 10.1093/jnci/93.8.618

M. Matuszak, D. Yan, I. Grills, and A. Martinez, Clinical Applications of Volumetric Modulated Arc Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.2, pp.608-624, 2010.
DOI : 10.1016/j.ijrobp.2009.08.032

P. Plowman, K. Cooke, and N. Walsh, Indications for tomotherapy/intensity-modulated radiation therapy in paediatric radiotherapy: extracranial disease, The British Journal of Radiology, vol.81, issue.971, 2008.
DOI : 10.1259/bjr/14878999

A. Joubert and N. Foray, Intrinsic radiosensitivity and DNA double-strand breaks in human cells]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.129-171, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00383866

D. Azria, Y. Pointreau, A. Toledano, and M. Ozsahin, [Factors of late radiosensitivity of normal tissues]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.4-5250, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00617711